9.2-9.8 | 临床研究顶刊快报
文摘
教育
2024-09-09 10:08
中国香港
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
1. Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, et al. Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma. New England Journal of Medicine. 2024;391(9):789-99.2. Ashina M, Phul R, Khodaie M, Löf E, Florea I. A Monoclonal Antibody to PACAP for Migraine Prevention. New England Journal of Medicine. 2024;391(9):800-9.3. Adeoye O, Broderick J, Derdeyn CP, Grotta JC, Barsan W, Bentho O, et al. Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke. New England Journal of Medicine. 2024;391(9):810-20.4. Zhang X-A, Ma Y-D, Zhang Y-F, Hu Z-Y, Zhang J-T, Han S, et al. A New Orthonairovirus Associated with Human Febrile Illness. New England Journal of Medicine. 2024;391(9):821-31.5. Graham AL, Cha S, Jacobs MA, Amato MS, Funsten AL, Edwards G, et al. A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users: A Randomized Clinical Trial. JAMA. 2024;332(9):713-21.6. Ryan CE, Fasaye G-A, Gallanis AF, Gamble LA, McClelland PH, Duemler A, et al. Germline CDH1 Variants and Lifetime Cancer Risk. JAMA. 2024;332(9):722-9.7. Lee EY, Gomes T, Drucker AM, Daneman N, Asaf A, Wu F, et al. Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions. JAMA. 2024;332(9):730-7.8. Valgimigli M, Hong S-J, Gragnano F, Chalkou K, Franzone A, da Costa BR, et al. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials. The Lancet. 2024;404(10456):937-48.9. Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, et al. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials. The Lancet. 2024;404(10456):949-61.10. Yang P, Pardon LP, Ho AC, Lauer AK, Yoon D, Boye SE, et al. Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study. The Lancet. 2024;404(10456):962-70.11. Sørensen M, Poulsen AH, Nøhr B, Khan J, Ketzel M, Brandt J, et al. Long term exposure to road traffic noise and air pollution and risk of infertility in men and women: nationwide Danish cohort study. BMJ. 2024;386:e080664.12. Vaccarella S, Li M, Bray F, Kvale R, Serraino D, Lorenzoni V, et al. Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study. BMJ. 2024;386:e077738.部分文字参考新英格兰医学前沿。
